Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Find Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Near You

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to better understand the role of immune system cells in lung diseases such as lung cancer, sarcoidosis, and chronic obstructive pulmonary disease (COPD). The investigators are studying how these immune cells can sometimes help the body defend itself, but in other cases may contribute to cancer growth or long-term lung inflammation. Although recent treatments like immunotherapy have improved cancer care, only a small proportion of patients currently benefit from these therapies. One goal of this research is to understand why some patients do not respond or develop resistance to treatment. The knowledge gained from this study may help researchers develop more effective and personalized treatments for people with lung diseases in the future.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 80
Healthy Volunteers: t
View:

• Diagnosis of lung cancer

• Presence of precancerous lung lesions

• Patients with a chronic inflammatory lung disease (sarcoidosis or chronic obstructive pulmonary disease \[COPD\]) prior to any treatment

• Control group: individuals without known lung disease

• Children and adolescents weighing ≥ 10 kg with genetically confirmed chronic granulomatous disease (CGD)

• Adults scheduled to undergo orthopedic surgery during which a bone marrow sample will be collected

Locations
Other Locations
Belgium
Cliniques universitaires saint Luc
RECRUITING
Brussels
Contact Information
Primary
Frank Aboubakar Nana, MD; PhD
frank.aboubakar@saintluc.uclouvain.be
0032 2 764 85 19
Backup
Kim Henquin, Study nurse
kim.henquin@saintluc.uclouvain.be
0032 2 764 42 26
Time Frame
Start Date: 2025-02-17
Estimated Completion Date: 2032-02-17
Participants
Target number of participants: 425
Treatments
Other: Patients with precancerous lung lesions
Patients with precancerous lung lesions under clinical monitoring
Active_comparator: Lung cancer
Patients with a diagnosis of lung cancer (all stages)
Other: Sarcoidosis and COPD
Patients with chronic inflammatory lung diseases
Other: Control group
Control group of volunteers without known lung disease
Other: chronic granulomatous disease
Children and adolescents weighing ≥10 kg with chronic granulomatous disease
Other: Adults undergoing orthopedic surgery following hip or femur fracture
Bone Marrow of Adults undergoing orthopedic surgery following hip or femur fracture
Sponsors
Leads: Université Catholique de Louvain

This content was sourced from clinicaltrials.gov